PL
PL · PL · PL-100438928
Reblozyl
ATC B03XA06
Last synced from URPL (Poland) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG
CountryPL (PL)
ATC codeB03XA06
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin07640133688251
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań",
"source": "urpl",
"strength": "75 mg",
"packaging": "07640133688251 ¦ Rpz ¦ EU/1/20/1452/002 ¦ 137067\n1 fiol. \n¦ UR/Z/4b/136/24 - 07640133688251 ¦ UR/Z/4b/194/25 - 07640133688251",
"substance": null,
"common_name": "Luspaterceptum",
"pl_product_id": "100438928",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code B03XA06.
- 🇺🇸ReblozylCelgene Corporation
- ISReblozylBristol-Myers Squibb Pharma EEIG*
- ISReblozylBristol-Myers Squibb Pharma EEIG*
- DKReblozylBristol-Myers Squibb Pharma EEIG
- PLReblozylBristol-Myers Squibb Pharma EEIG
- NOReblozylBristol-Myers Squibb Pharma EEIG (1)
- DKReblozylBristol-Myers Squibb Pharma EEIG
- 🇺🇸ReblozylCelgene Corporation
Access this data programmatically
Query Reblozyl and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.